Carlson Capital Management decreased its stake in Abbott Labs (ABT) by 52.73% based on its latest 2019Q1 regulatory filing with the SEC. Carlson Capital Management sold 26,122 shares as the company’s stock rose 2.86% with the market. The institutional investor held 23,416 shares of the major pharmaceuticals company at the end of 2019Q1, valued at…